A Day With PoNS
A Day With PoNS® You might already know that PoNS Therapy® is used to improve walking ability for people with multiple sclerosis (MS)—but did you know that it can be tailored to your specific needs and schedule? PoNS Therapy is a combination of physical therapy (PT) and the use of the PoNS® (Portable Neuromodulation Stimulator) […]
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study September 30, 2024 at 8:00 AM EDT — Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase 1 to end of treatment at week 14 — — Confirms the therapeutic […]
How PoNS® Brings Physical Therapy to the Next Level
How PoNS® Brings Physical Therapy to the Next Level PoNS, the Portable Neuromodulation Stimulator, is an orally-applied therapy proven to increase walking ability for people with multiple sclerosis (MS). PoNS must be used in conjunction with physical therapy (PT). Together, PoNS and PT are referred to as PoNS Therapy®. Boost PT with PoNS and Get […]
PoNS® Real Stories: How Mariska Improved Her Ability to Walk
PoNS® Real Stories: How Mariska Improved Her Ability to Walk PoNS is proud to improve walking ability for those with multiple sclerosis (MS), so they can Get Back In Step With Life. Mariska, a PoNS-user with MS, spoke to us about her own PoNS journey. Read on to see how PoNS enhanced her mobility, and […]
Helius Medical is partnering with Lovell® Government Services to make PoNS® available to Veterans with multiple sclerosis (MS)
Helius Medical is Partnering with Lovell® Government Services to Make PoNS® Available to Veterans with Multiple Sclerosis (MS) Helius Medical is partnering with Lovell® to help Veterans living with MS get access to the innovative Portable Neuromodulation Stimulator (PoNS). PoNS is a nonsurgical device that, when paired with physical rehabilitation therapy, improves the walking ability […]
Go for 4! Better yet—Aim for 8!
Go for 4! Better yet—Aim for 8! Study shows individuals with MS reached an average of an 8-point gait improvement when combining physical therapy with PoNS® Walking is an important aspect of everyday life. However, individuals with multiple sclerosis (MS) often experience difficulty walking, also known as gait deficit. In fact, it can be one […]
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ April 3, 2024 at 7:05 AM EDT — Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) —— Over 28,000 cases of multiple sclerosis (MS) are reported to the VA […]
Six Tips for Caregivers of Adults Living with MS
Six Tips for Caregivers of Adults Living with MS As a caregiver, you play a pivotal role in supporting a person with multiple sclerosis (MS) throughout their journey. You do so much to help them both physically and emotionally, providing much needed companionship. While you are taking care of your loved one, it is important […]
Building a community—an important step in your rehabilitation journey
Building a Community—an Important Step in Your Rehabilitation Journey Multiple sclerosis (MS) can touch every aspect of your life. It doesn’t only impact your coordination or mobility—it can also lead to social isolation. This leaves a heavy toll on your social engagement—limiting your ability to participate in activities you once enjoyed so much. Catching a […]
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller March 4, 2024 at 7:00 AM EST — Significant step toward reimbursement for the only medical device approved in the U.S. for treatment of gait deficit due to multiple sclerosis (“MS”) — — Proceeds from recent stock issuances through the […]